David B. Weiner, Ph.D.
Affiliations: | Pathology & Laboratory Medicine | University of Pennsylvania, Philadelphia, PA, United States |
Area:
DNA vaccine, HIVGoogle:
"David Weiner"Mean distance: 15266.6
Children
Sign in to add trainee| Alfred Hyoungju Kim | research assistant | 1995-1997 | University of Pennsylvania School of Medicine |
| Michael A. Chattergoon | grad student | 2003 | Penn |
| Dominick J. Laddy | grad student | 2008 | Penn |
| Kimberly A. Kraynyak | grad student | 2009 | Penn |
| Lauren A. Hirao | grad student | 2010 | Penn |
| Krystle A. Kuhs | grad student | 2011 | Penn |
| Nyamekye Obeng-Adjei | grad student | 2013 | Penn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gary EN, Tursi NJ, Warner BM, et al. (2023) Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge. Frontiers in Immunology. 14: 1138609 |
| Park DH, Liaw K, Bhojnagarwala P, et al. (2023) Multivalent delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape. Molecular Therapy Oncolytics. 28: 249-263 |
| Tursi NJ, Xu Z, Helble M, et al. (2023) Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression . Frontiers in Immunology. 14: 1072810 |
| Tursi NJ, Xu Z, Kulp DW, et al. (2023) Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1880 |
| Jacobson JM, Zahrieh D, Strand CA, et al. (2022) Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prevention Research (Philadelphia, Pa.). OF1-OF11 |
| Gary EN, Tursi NJ, Warner B, et al. (2022) Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo. Cell Reports. Medicine. 100693 |
| Cusimano GM, Gary EN, Bell MR, et al. (2022) Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1. Journal of Immunology (Baltimore, Md. : 1950). 209: 118-127 |
| Aisenberg LK, Rousseau KE, Cascino K, et al. (2022) Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses. Jci Insight |
| Walters JN, Schouest B, Patel A, et al. (2022) Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates. Vaccine. 40: 2960-2969 |
| Xu Z, Walker S, Wise MC, et al. (2022) Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer. Nature Communications. 13: 695 |